Men while, the BSE sensex was up 388.78 poins, or 1.43%,to 27,515.68
on BSE ,so far 55,127 Shares were traded in the counter,compared with average daily volume of 2.89 lakh share in the past one quarter.The stock hit a high of RS 789.60 and a low of RS 782 so far during the day ,the stock hit a 52-week high of rs 965.15 on 2015 .the stock hit a 52-week low of 706.40 on novbember 2015. the stock had outperforment the market over thw past one month till 19 july 2016, gaining 5.3% compared with 4.36%rise in the sensex.The scriphad ,however,underperformed the market in past one droping 6.52% as against sensex 7.64%rise
Te large-cap company has a equity capital of 240.68 crore.face value per share is Re Sun pharmaceutical industries annouced that one of its subsidiaries recived final approvel from US Food&Drug Asministration for its abbrevaited New Drug Apllication for generatic version of crestor,Rosuvastain Calcium tablets 5 mg ,10 mg,20 mg and 40 mg
Rosuvastatin calcium tablets are therapeutic equivalents of IPR Pharmaceuticals, Inc.'s crestor tablets.as per IMS MAT may 2016 data ,these tablets have anual seles of approximatly $6.8 billion i the US.these tablets are idicated for the treatment of adult patient with Hypertring lyceridemia, primary Dysbetaliporotemia
Sun Pharmaceutical Industries' (Sun Pharma) consolidated net profit rose92.7% to Rs 1713.69 crore on 21.5% growth in net sales to Rs 7413.87 crore in Q4 March 2016 over Q4 March 2015.
Sun Pharmaceutical Industries is a specialty generic pharmaceutical company and India's top pharmaceutical company.
